Femme Homme
- | Pays :
- India
- | Organes : -
- | Spécialités : -
Extrait
Experience with substituting carboplatin for cisplatin is limited in advanced and recurrent cervix cancer and there has been no counterpart to GOG 158, which documented therapeutic equivalency of cisplatin/paclitaxel and carboplatin/paclitaxel for treatment of ovarian cancer, performed in a cervix cancer population.
Critère d'inclusion
- Metastatic Carcinoma to the Uterine Cervix ,Recurrent Carcinoma Cervix ,Cervix Carcinoma Recurrent